Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ (IC50 : 2.5 nM; in cell-free assays) ; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
Product Specifications
CAS Number
1146702-54-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
415.42
Molecular Formula
C22H18FN7O
Notes
Research use only, not for human use.
Receptor
P110δ
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
161587 100 mg
4,4,5,5-Tetramethyl-2- (6-methyl-1-cyclohexen-1-yl) -1,3,2-dioxaborolane
Ask
View Details 
043717 200 µL
Vascular Endothelial Growth Factor D, ID (VEGF4, VEGF-D, c-fos-induced growth factor, FIGF, VEGFD) discontinued
Ask
View Details 